BNET Industries
Market Cap:$346.5K
Last Fiscal Year Sales:$2.2M
- Public
- US
Dow Jones Description
Cyberkinetics Neurotechnology Systems, Inc., a leader in the neurotechnology industry, is developing neural stimulation, sensing and processing technology to improve the lives of those with severe paralysis resulting from spinal cord injuries, neurological disorders and other conditions of the nervous system. Cyberkinetics' product development pipeline includes: the FDA cleared-to-market NeuroPort? System, a neural monitor designed for acute inpatient applications and labeled for temporary (less than 30 days) recording and monitoring of brain electrical activity; the Andara? Oscillating Field Stimulator? (OFS) Device, an investigative device designed to stimulate regeneration of the neural tissue surrounding the spinal cord; and the BrainGate System, an investigative device designed to provide communication and control of a computer, assistive devices, and, ultimately, limb movement.
Founder and Chief Scientific Officer
John P. DonoghueContact Information
100 Foxborough Boulevard
Suite 240
Foxborough, Massachusetts 02035
508-549-9981
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
News & Analysis
Filter by
cyberkinetics neurotechnology systems inc. and massachusetts general hospital - All News and Analysis
Researchers to Report Data from Cyberkinetics' BrainGate System at 2006 Annual Meeting of the Society for Neuroscience
- 2006-10-11
FOXBOROUGH, Mass. -- Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN; Cyberkinetics) is scheduled to report its latest findings with respect to the Company's BrainGate Neural Interface System BrainGate System in presentations at the Annual Meeting of the Society for Neuroscience in Atlanta, Georgia. The presentations will include scientific, mathematical data and practical...
John P. Donoghue Honored for Cyberkinetics' Groundbreaking BrainGate™ Brain-Computer Interface at the 'Popular Mechanics 2005 Breakthrough Awards'
- 2005-09-30
FOXBOROUGH, Mass. -- Cyberkinetics' Founder Selected Based On Potential of Innovative BrainGateTM System to Improve Lives of Motor-Impaired People Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN) Cyberkinetics announced today that John P. Donoghue, Ph.D., the Company's Chief Scientific Officer and Professor and Chairman of the Department of Neuroscience at Brown...
ALS Patients Offered Access to Cyberkinetics' BrainGate™ System in New Pilot Study at Massachusetts General Hospital
- 2005-08-22
FOXBOROUGH, Mass. -- Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) Cyberkinetics today announced the start of a new pilot clinical study of the BrainGateTM Neural Interface System, a brain-computer interface BCI, in individuals diagnosed with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) or other progressive motor neuron diseases. Cyberkinetics received regulatory...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| John P. Donoghue | Founder and Chief Scientific Officer |
| Kurt H. Kruger | CFO |
| J. Christophe Flaherty | Executive Vice President, Technology and Intellectual Property |
| Mark A. Carney | Executive Vice President |
| Kimi E. Iguchi | Vice President, Finance |
| Mark P Carthy |
| Organization | Position | Status |
|---|---|---|
| Oxford Bioscience Partners | Chief Scientific Officer, Director | Current |
| Cyberkinetics Neurotechnology Systems, Inc. | Founder and Chief Scientific Officer | Current |
| Cyberkinetics Neurotechnology Systems, Inc. | Board of Directors | Current |
| Brown University | Executive Director | Former |
| Brown University | Ph.D. in Neuroscience | Former |
| University of Vermont | M.S. in Anatomy | Former |
| Boston University | A.B. | Former |
| Organization | Position | Status |
|---|---|---|
| Cyberkinetics Neurotechnology Systems, Inc. | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| Cyberkinetics Neurotechnology Systems, Inc. | Executive Vice President, Technology and Intellectual Property | Current |
| Viasys Healthcare Inc. | Vice President of Engineering and New Technologies | Former |
| Biogen Idec, Inc. | Senior Manager of External Reporting | Former |
| Massachusetts Institute of Technology | B.S. in Aeronautical and Electrical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Cyberkinetics Neurotechnology Systems, Inc. | Executive Vice President | Current |
| Cyberkinetics Neurotechnology Systems, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Cyberkinetics Neurotechnology Systems, Inc. | Vice President, Finance | Current |
| Global Life Science Ventures AG | Vice President, Finance | Current |
| Oxford Bioscience Partners | Vice President, Finance | Current |
| Millennium Pharmaceuticals, Inc. | Senior Director | Former |
| Continental Cablevision | Director of Financial Reporting | Former |
| PricewaterhouseCoopers | Senior Audit Manager | Former |
| Biogen Idec, Inc. | Senior Manager of External Reporting | Former |
| Biogen, Inc. | Senior Manager | Former |
| Cooper's Inc. | Accountant | Former |
| Northeastern University | M.B.A. | Former |
| Drew University | B.A. In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Astex Therapeutics Limited | Founder of Orion Healthcare Equities | Current |
| Oxford Bioscience Partners | General Partner | Current |
| Dynogen Pharmaceuticals, Inc. | General Partner, Oxford Bioscience Partners | Current |
| West Membership Co | Venture Partner, Oxford Bioscience Partners | Current |
| Cyberkinetics Neurotechnology Systems, Inc. | Current | |
| Oxford Bioscience Partners | Director | Current |
| Astex Therapeutics Limited | Board of Directors | Current |
| Impactrx, Inc. | Director | Current |
| Xanthus Pharmaceuticals, Inc. | Board of Directors | Current |
| Global Life Science Ventures AG | Board of Directors | Current |
| Scion Pharmaceuticals, Inc. | Director | Current |
| Xanthus, Inc. | Board of Directors | Current |
| Solexa, Inc. | Director | Current |
| Salix Pharmaceuticals, Inc. | Investor | Current |
| Cubist Pharmaceuticals, Inc. | Chief Business Officer | Former |
| Vertex Pharmaceuticals Incorporated | Senior Director of Business Development | Former |
| Dendreon Corporation | Director | Former |
| Ensemble, LLC | Investor | Former |
| Xanthus, Inc. | Investor | Former |
| Solexa, Inc. | Investor | Former |
| Impactrx, Inc. | Investor | Former |
| Harvard Business School | Mba | Former |
| University of Missouri | M.S. In Chemical Engineering | Former |
| University College Dublin | B.E. In Chemical Engineering | Former |
Industry Transcripts by Seeking Alpha
-
Accenture Ltd. F1Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about ACN
-
FedEx F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about FDX
-
Fifth Street Finance Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 10, 2009about FSC
-
SAIC, Inc. F3Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about SAI
-
Casella Waste Systems Inc. F2Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 03, 2009about CWST
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Newspapers Lose Out As MSNBC.com Snaps Up EveryBlock 6 votes
Presented by American Express